NEW YORK (GenomeWeb) – Sigma-Aldrich said today that its third quarter revenues were up 4 percent year over year.

The company reported total revenues of $690 million for the three months ended Sept. 30, up from $664 million in Q3 2013 and in line with the average analyst estimate of $689.8 million.

The Research business unit posted $347 million in revenues, up from $341 million a year ago, Applied revenues grew to $170 million from $154 million, and SAFC Commercial revenues increased to $173 million from $169 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Wall Street Journal reports there is uncertainty surrounding whether He Jiankui's embryo editing did what he said it did.

Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.

Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, NJ.com writes.

In Nature this week: genomic analysis of the invasive fall webworm, amp of constrained coding regions within the human genome, and more.